Edition:
United States

Aralez Pharmaceuticals Inc (ARLZ.OQ)

ARLZ.OQ on NASDAQ Stock Exchange Global Select Market

1.41USD
14 Dec 2017
Change (% chg)

-- (--)
Prev Close
$1.41
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
118,865
52-wk High
$5.04
52-wk Low
$0.95

Chart for

About

Aralez Pharmaceuticals Inc. is a Canada-based specialty pharmaceutical company. The Company focuses on acquiring, developing and commercializing products in cardiovascular, pain and other areas. The Company's products include Fibricor, Cambia, Fiorinal, Fiorinal C, Soriatane, Bezalip SR, NeoVisc, Uracyst, Durela, Proferrin,... (more)

Overall

Beta: --
Market Cap(Mil.): $94.31
Shares Outstanding(Mil.): 66.89
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 32.50 16.04
EPS (TTM): -- -- --
ROI: -- 15.11 35.70
ROE: -- 16.59 15.40

BRIEF-Aralez Pharmaceuticals files for mixed shelf offering of up to $100 mln - SEC filing‍​

* Aralez Pharmaceuticals Inc - files for mixed shelf offering of up to $100 million - SEC filing‍​ Source text: (http://bit.ly/2zrTHPn) Further company coverage:

Nov 09 2017

BRIEF-Aralez sees 2018 net revenues $140 mln to $160 mln‍​

* Aralez announces third quarter 2017 financial results and achieves profitability on an adjusted EBITDA basis for the first time in the third quarter

Nov 09 2017

BRIEF-Aralez qtrly loss per share ‍$0.42​

* Aralez Pharmaceuticals Inc - ‍total revenues for 3 months ended June 30, 2017 were $27.6 million compared to $12.6 million for three months ended June 30, 2016​

Aug 09 2017

Earnings vs. Estimates